Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factor.
| Image |  |
|---|---|
| Description | scientific article published in August 2005 |
| Author/s |
author: Hong Suk Song Moon Hee Lee Young-Hyuck Im Seock-Ah Im Tae-You Kim Yeon Hee Park Yung-Jue Bang |
| Publication date | August 1, 2005 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |